Effects of Different Early Intensive Therapies on Long-term β-cell Function

NCT01471808 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

264

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: CSII
DRUG: CSII, Metformin, Pioglitazone
DRUG: CSII, Sitagliptin

Sponsor

Sun Yat-sen University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]